| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/09/1995 | CA2168252A1 Thiazole derivatives as lipoxygenase inhibitors |
| 02/09/1995 | CA2168233A1 Perhydroisoindole derivatives as substance p antagonists |
| 02/09/1995 | CA2168044A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
| 02/09/1995 | CA2167818A1 Therapeutic compound - fatty acid conjugates |
| 02/09/1995 | CA2167411A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
| 02/09/1995 | CA2153236A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 02/08/1995 | EP0637586A1 2-(Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives, their preparation and their use as acetylcholinesterase inhibitors |
| 02/08/1995 | EP0637450A2 Composition for revitalizing scar tissue |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637308A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 02/08/1995 | EP0637307A1 Imidazole, triazole and tetrazole derivatives |
| 02/08/1995 | EP0637306A1 4-imidomethyl-1- 2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht 2?-antagonists, their preparation and use in therapy |
| 02/08/1995 | EP0637303A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists |
| 02/08/1995 | EP0637299A1 20-methyl-substituted vitamin d derivates. |
| 02/08/1995 | EP0637297A1 Compounds having selectivity for retinoid x receptors |
| 02/08/1995 | EP0637245A1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation |
| 02/08/1995 | EP0637242A1 Agents for treating substance abuse disorders |
| 02/08/1995 | EP0637240A1 Pharmaceutical compositions containing 3 and 4-substituted 2(5h)-furanones for inhibiting bone loss |
| 02/08/1995 | EP0637237A1 Calcium receptor-active molecules |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/08/1995 | CN1098411A Oxazolidinedione derivatives, their production and use |
| 02/08/1995 | CN1098408A Heterocyclic inhibitors of farnesyl protein transferase |
| 02/08/1995 | CN1098406A New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| 02/08/1995 | CN1098286A PH-triggered osmotic bursting delivery devices |
| 02/07/1995 | US5387709 Bronchodilator agents, anticoagulants, vasodilation |
| 02/07/1995 | US5387685 Bicyclic amines; resensitize multiple drug resistant cells to chemotherapeutic agents |
| 02/07/1995 | US5387615 L-deprenyl for treating immune system dysfunction and compositions for same |
| 02/07/1995 | US5387606 Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss |
| 02/07/1995 | US5387604 Useful in treatment of anxiety, depression, migraine, stroke and hypertension |
| 02/07/1995 | US5387601 Medicament |
| 02/07/1995 | US5387591 Pyrrolidine compounds |
| 02/07/1995 | US5387586 (Aryl(alkyl)carbonyl)-heterocyclic compounds, compositions and use |
| 02/07/1995 | CA2029704C Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| 02/06/1995 | CA2129483A1 Bicyclic derivatives of imidazole, process for their preparation, new intermediate compounds thus obtained, their application as medicaments, and pharmaceutical compositions containing them |
| 02/06/1995 | CA2129462A1 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives |
| 02/05/1995 | CA2103938A1 Method and composition for revitalizing scar tissue |
| 02/03/1995 | CA2129279A1 Pharmaceutical composition and process |
| 02/03/1995 | CA2129274A1 Pharmaceutical composition |
| 02/03/1995 | CA2129179A1 Trisubstituted pyrimido[5,4-d]pyrimidines for modulating multi-drug resistance, pharmaceutical compositions containing these compounds and processes for their preparation |
| 02/02/1995 | WO1995003411A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | WO1995003409A1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 02/02/1995 | WO1995003405A2 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | WO1995003369A1 Storage stable partially neutralized acid compositions and uses |
| 02/02/1995 | WO1995003333A2 Tryptase inhibitor |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/02/1995 | WO1995003298A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST |
| 02/02/1995 | WO1995003292A1 Heteroaryl cycloalkenyl hydroxyureas |
| 02/02/1995 | WO1995003271A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/02/1995 | WO1995003266A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 02/02/1995 | WO1995003059A1 Bivalent sialyl lewis x saccharides |
| 02/02/1995 | WO1995003054A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | WO1995003053A1 Oxophthalazines for treating cachexia |
| 02/02/1995 | WO1994027583A3 Apoptosis inhibitors for treating neurodegenerative diseases |
| 02/02/1995 | CA2168110A1 Agonists and antagonists of human interleukin-10 |
| 02/02/1995 | CA2167805A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | CA2167721A1 Storage stable partially neutralized acid compositions and uses |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2166870A1 Enzymatic method for modification of recombinant polypeptides |
| 02/02/1995 | CA2164221A1 Tryptase inhibitor |
| 02/02/1995 | CA2145067A1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals |
| 02/02/1995 | CA2144521A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/01/1995 | EP0636626A1 Pyrazolopyrimidine Derivatives |
| 02/01/1995 | EP0636625A2 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 02/01/1995 | EP0636623A1 Indole derivatives as 5-HT1- like agonists |
| 02/01/1995 | EP0636611A2 Optically active 1,4-dihydropyridine derivatives and process for preparing the same |
| 02/01/1995 | EP0636609A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them |
| 02/01/1995 | EP0636369A1 Pyrimidones and imidazolinones for treatment of shock |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636175A1 Decorin fragments and methods of inhibiting cell regulatory factors |
| 02/01/1995 | EP0636131A1 Heteroaromatic 5-hydroxytryptamine receptor agonists |
| 02/01/1995 | EP0636125A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 02/01/1995 | EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same |
| 02/01/1995 | EP0636119A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 02/01/1995 | EP0636028A1 Self-assembling polynucleotide delivery system |
| 02/01/1995 | EP0636027A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 02/01/1995 | EP0549594B1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| 02/01/1995 | EP0500736B1 Recombinant vaccine for porcine pleuropneumonia |
| 02/01/1995 | EP0469125B1 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives |
| 02/01/1995 | EP0420877B1 A method and composition for preventing surgical adhesions |
| 02/01/1995 | CN1098098A 哌嗪衍生物 Piperazine derivatives |
| 02/01/1995 | CN1098094A Aryl substituted heterocycles |
| 02/01/1995 | CN1097998A Shengliyangshengye-nourishing liquid for building up strength |
| 02/01/1995 | CN1097984A Methods for administering biological agents and microparticle compositions useful in these and other methods |
| 01/31/1995 | US5386025 Calcium channel compositions and methods |
| 01/31/1995 | US5385943 Use of topically applicable preparations for treatment of presbyderma |
| 01/31/1995 | US5385941 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| 01/31/1995 | US5385937 Preventing peroxide generation from mercaptan groups and endothelial injury |
| 01/31/1995 | US5385935 Method for the inhibition of restenosis associated with coronary intervention |
| 01/31/1995 | US5385932 Anticholesterol, antilipemic agents |
| 01/31/1995 | US5385928 Antiserotonine agent |
| 01/31/1995 | US5385923 Treatment of degenerative diseases |
| 01/31/1995 | US5385921 Treatment for neurodegeneration, alzheimer's disease, huntington's chorea; antihypoxic agents, antiischemic agents |
| 01/31/1995 | US5385918 Aminomethylene-peptides as immunosuppressants |
| 01/31/1995 | US5385912 Multicyclic tertiary amine polyaromatic squalene synthase inhibitors |
| 01/31/1995 | US5385903 Pharmaceutical agent for treatment of withdrawal symptoms |
| 01/31/1995 | US5385899 Aminoalkyl-substituted 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes |